FULGENT GENETICS, INC. Deferred Tax Assets, Operating Loss Carryforwards
FULGENT GENETICS, INC. (FLGT) had Deferred Tax Assets, Operating Loss Carryforwards of $20.56 million as of 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-27
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $20.56M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $11.88M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $17.50M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $16.34M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $20.56M 10-K · filed 2026-02-27 |
| 2024-12-31 | $11.88M 10-K · filed 2026-02-27 |
| 2023-12-31 | $17.50M 10-K · filed 2025-02-28 |
| 2022-12-31 | $16.34M 10-K · filed 2024-02-28 |
| 2021-12-31 | $199.00K 10-K · filed 2023-02-28 |
| 2020-12-31 | $206.00K 10-K · filed 2022-02-28 |
| 2019-12-31 | $445.00K 10-K · filed 2022-02-28 |
| 2018-12-31 | $699.00K 10-K · filed 2020-03-13 |
| 2017-12-31 | $148.00K 10-K · filed 2019-03-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |